Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1037 of 1,261

  1. EP 2044019

    3-OXOISOINDOLIN-1-CARBONSÄUREAMIDDERIVATE ALS ANALGETIKA

    ASTRAZENECA AB [SE] · Granted Apr 8, 2009 · Expires Apr 3, 2029

    granted

  2. AR 064495

    DERIVADOS DE PIPERIDIN-CARBONILFENIL SULFONAMIDAS

    ASTRAZENECA AB [SE] · Granted Apr 8, 2009 · Expires Apr 3, 2029

    granted

  3. EP 2044050

    NEUE PYRIDINANALOGA

    ASTRAZENECA AB [SE] · Granted Apr 8, 2009 · Expires Apr 3, 2029

    granted

  4. EP 2044063

    FÜR DIE BEHANDLUNG VON KREBS GEEIGNETE PYRIMIDINDERIVATE

    ASTRAZENECA AB [SE] · Granted Apr 8, 2009 · Expires Apr 3, 2029

    granted

  5. US 7514410

    Hepatitis C therapies

    BioCryst Pharmaceuticals, Inc. · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  6. US 7514415

    Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  7. US 7514425

    Short-acting sedative hypnotic agents for anesthesia and sedation

    Theravance, Inc. · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  8. US 7514448

    Azaindoles useful as inhibitors of rock and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  9. US 7514436

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  10. US 7514529

    Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  11. US 7514467

    Crystalline solids of carvedilol and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  12. US 7514095

    Fabrication of drug loaded biodegradable polymer fibers

    The Board of Regents of the University of Texas System · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  13. US 7514096

    Triacylglycerols of enriched CLA content

    Aker Biomarine AS · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  14. US 7514441

    Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents

    Takeda Pharmaceutical Company Limited · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  15. US 7514434

    Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof

    Rigel Pharmaceuticals, Inc. · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  16. US 7514414

    Suppressors of CpG oligonucleotides and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  17. US 7514558

    Biphenyl derivatives

    Theravance, Inc. · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  18. EP 2041176

    ANTIKÖRPERMOLEKÜLE FÜR HUMANES IL-17

    ASTRAZENECA AB [SE] · Granted Apr 1, 2009 · Expires Mar 27, 2029

    granted

  19. EP 2041112

    NEUE PYRIDINANALOGA

    ASTRAZENECA AB [SE] · Granted Apr 1, 2009 · Expires Mar 27, 2029

    granted

  20. EP 2041135

    ALS MODULATOREN VON TLR7 WIRKENDE 8-OXOADENINDERIVATE

    ASTRAZENECA AB [SE] · Granted Apr 1, 2009 · Expires Mar 27, 2029

    granted

  21. US 7511053

    Spiroazacyclic compounds as monoamine receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  22. US 7510710

    Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor

    The Regents of the University of Colorado · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  23. US 7511015

    Modified defensins and their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  24. US 7511124

    Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.